Treatment of early-stage diabetic nephropathy with Siddha drug Sirupeelai Kudineer: A case series
2024

Treatment of Diabetic Nephropathy with Siddha Drug

Sample size: 4 publication Evidence: low

Author Information

Author(s): Parvathy P., Lekha G.S., Aparna S., Kanagarajan A.

Primary Institution: Siddha Regional Research Institute, Thiruvananthapuram, India

Hypothesis

Can the Siddha drug Sirupeelai Kudineer improve renal function in patients with early-stage diabetic nephropathy?

Conclusion

The study suggests that Sirupeelai Kudineer may improve renal function and quality of life in patients with diabetic nephropathy.

Supporting Evidence

  • Blood urea levels decreased in all patients after treatment.
  • Serum creatinine levels improved in all patients after treatment.
  • Estimated GFR improved in three out of four patients after treatment.
  • Symptomatic improvement was observed in all patients.

Takeaway

Four patients with kidney problems from diabetes took a special herbal medicine and felt better, showing improvements in their kidney health.

Methodology

The study involved four patients treated with the Siddha formulation Sirupeelai Kudineer, with assessments of renal function and quality of life before and after treatment.

Limitations

The study is limited by its small sample size and lack of a control group.

Participant Demographics

All four participants were male, aged between 60 and 69 years, with a history of diabetes.

Digital Object Identifier (DOI)

10.1016/j.jaim.2024.100993

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication